Form 8-K - Current report:
SEC Accession No. 0001104659-12-019206
Filing Date
2012-03-19
Accepted
2012-03-19 16:30:47
Documents
1
Period of Report
2012-03-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K a12-7496_18k.htm 8-K 25207
  Complete submission text file 0001104659-12-019206.txt   26459
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 12700880
SIC: 2834 Pharmaceutical Preparations